PREV_PKDL project strengthens flow cytometry capacity in Africa
Knowledge sharing and capacity building are key to advance scientific research and innovation. One of the main objectives of the...
This project is part of the EDCTP2 Programme supported by the European Union (RIA2016V-1640)
Search
EVI
- Aug 7, 2020
The potential impact of human visceral leishmaniasis vaccines on population incidence
New article was published by Prof. Paul Kaye in PLOS Neglected Tropical Diseases.
EVI
- Jul 8, 2020
New article on PREV_PKDL's contribution in the fight against leishmaniasis
The article titled "Expanding research capacity into neglected tropical diseases" by Prof Dr Paul Kaye was published on July 8th on ...
EVI
- Jun 15, 2020
Clinical Lab International article on flow cytometry's role in combating leishmaniasis by Prof Kaye
Prof Kaye, partner in the PREV_PKDL project, explores how flow cytometry can help to diagnose and develop a vaccine against leishmaniasis.
EVI
- May 14, 2020
Beckman Coulter Press Release on PREV_PKDL: New Flow Cytometry Centre of Excellence for East Africa
One of the aims of PREV_PKDL project is to establish New Flow Cytometry Centre of Excellence for East Africa. On 13 of May Beckman...
EVI
- Apr 25, 2019
PREV_PKDL Annual Meeting 2019
The first PREV_PKDL annual meeting was successfully organised in Addis Ababa, Ethiopia
EVI
- Feb 24, 2019
Workshop on EC/EDCTP financial requirements
A financial workshop was organised by EVI at Addis Ababa, Ethiopia to train the financial managers working on the PREV_PKDL project.